Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway

Ovarian cancer is one of the most common causes of death from gynecologic tumors and is an important public health issue. Ghrelin is a recently discovered bioactive peptide that acts as a natural endogenous ligand of the growth hormone secretagogue receptor (GHSR). Several studies have identified th...

Full description

Bibliographic Details
Main Author: Bai,R.X. (author)
Other Authors: Wang,W.P. (author), Zhao,P.W. (author), Li,C.B. (author)
Format: article
Language:eng
Published: 2016
Subjects:
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000300602
Country:Brazil
Oai:oai:scielo:S0100-879X2016000300602